Castleman Disease, An Issue of Hematology/Oncology Clinics, 1st Edition
Authors :
Frits van Rhee & Nikhil C. Munshi
This issue of Hematology/Oncology Clinics, edited by Dr. Frits van Rhee and Dr. Nikhil C. Munshi, focuses on Castleman’s Disease. Topics include, but are not limited to, Epidemiology; Pathogenesis; Role of Interleukin 6 in Castleman Disease; Pathol ...view more
This issue of Hematology/Oncology Clinics, edited by Dr. Frits van Rhee and Dr. Nikhil C. Munshi, focuses on Castleman’s Disease. Topics include, but are not limited to, Epidemiology; Pathogenesis; Role of Interleukin 6 in Castleman Disease; Pathology, Diagnosis; Unicentric Castleman Disease; Treatment of HHV8 related Multicentric Castleman Disease; Treatment of HHV8 negative Castleman Disease; TAFRO Syndrome; POEMS; and more.
This issue of Hematology/Oncology Clinics, edited by Dr. Frits van Rhee and Dr. Nikhil C. Munshi, focuses on Castleman’s Disease. Topics include, but are not limited to, Epidemiology; Pathogenesis; Role of Interleukin 6 in Castleman Disease; Pathology, Diagnosis; Unicentric Castleman Disease; Treatment of HHV8 related Multicentric Castleman Disease; Treatment of HHV8 negative Castleman Disease; TAFRO Syndrome; POEMS; and more.
Author Information
By Frits van Rhee, MD, PhD, MRCP(UK), FRCPath, Director of Clinical Research
Professor of Medicine
Myeloma Institute for Research and Therapy
University of Arkansas for Medical Sciences and Nikhil C. Munshi, MD, Director of Basic and Correlative Science, Jerome Lipper Multiple Myeloma Center
Senior Physician
Professor of Medicine, Harvard Medical School
Hematologic Oncology
https://www.us.elsevierhealth.com/castleman-disease-an-issue-of-hematologyoncology-clinics-9780323582896.html3303Castleman Disease, An Issue of Hematology/Oncology Clinicshttps://www.us.elsevierhealth.com/media/catalog/product/9/7/9780323582896.jpg70.84108.99USDInStock/Medicine/Hematology/Clinics/Clinics1374388725525504113841826925145120This issue of Hematology/Oncology Clinics, edited by Dr. Frits van Rhee and Dr. Nikhil C. Munshi, focuses on Castleman’s Disease. Topics include, but are not limited to, Epidemiology; Pathogenesis; Role of Interleukin 6 in Castleman Disease; Pathology, Diagnosis; Unicentric Castleman Disease; Treatment of HHV8 related Multicentric Castleman Disease; Treatment of HHV8 negative Castleman Disease; TAFRO Syndrome; POEMS; and more. This issue of Hematology/Oncology Clinics, edited by Dr. Frits van Rhee and Dr. Nikhil C. Munshi, focuses on Castleman’s Disease. Topics include, but are not limited to, Epidemiology; Pathogenesis; Role of Interleukin 6 in Castleman Disease; Pathology, Diagnosis; Unicentric Castleman Disease; Treatment of HHV8 related Multicentric Castleman Disease; Treatment of HHV8 negative Castleman Disease; TAFRO Syndrome; POEMS; and more.00add-to-cart97803235828962017ProfessionalBy Frits van Rhee, MD, PhD, MRCP(UK), FRCPath and Nikhil C. Munshi, MD20181Book152w x 229h (6.00" x 9.00")Elsevier0Dec 4, 2017IN STOCK - This may take up to 5 business days to shipBy <STRONG>Frits van Rhee</STRONG>, MD, PhD, MRCP(UK), FRCPath, Director of Clinical Research
Professor of Medicine
Myeloma Institute for Research and Therapy
University of Arkansas for Medical Sciences and <STRONG>Nikhil C. Munshi</STRONG>, MD, Director of Basic and Correlative Science, Jerome Lipper Multiple Myeloma Center
Senior Physician
Professor of Medicine, Harvard Medical School
Hematologic OncologyClinicsClinicsThe Clinics: Internal MedicineNoNoNoNoPlease SelectPlease SelectPlease Select
